CVS collects record sum for ALS research

CVS/pharmacy has raised a record-breaking $4.4 million for amyotrophic lateral sclerosis (ALS) research through its in-store fund-raising efforts, which took place from June 8 to 28. The chain said this is the seventh year it has organized this fund-raising campaign. ALS, a progressive degeneration of motor nerves in the brain and spinal cord leading to paralysis and death, is an orphan disease that has no known cause or cure.

To see more Daily News articles, click here.

To go to the Drug Topics homepage, .